These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity. Rao P; Wen X; Lo JH; Kim S; Li X; Chen S; Feng X; Akbari O; Yuan W J Virol; 2018 Nov; 92(22):. PubMed ID: 30185591 [TBL] [Abstract][Full Text] [Related]
3. A Thr/Ser dual residue motif in the cytoplasmic tail of human CD1d is important for the down-regulation of antigen presentation following a herpes simplex virus 1 infection. Liu J; Glosson NL; Du W; Gervay-Hague J; Brutkiewicz RR Immunology; 2013 Oct; 140(2):191-201. PubMed ID: 23710894 [TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. Rao P; Pham HT; Kulkarni A; Yang Y; Liu X; Knipe DM; Cresswell P; Yuan W J Virol; 2011 Aug; 85(16):8093-104. PubMed ID: 21653669 [TBL] [Abstract][Full Text] [Related]
5. Viral evasion of antigen presentation: not just for peptides anymore. Van Kaer L; Joyce S Nat Immunol; 2006 Aug; 7(8):795-7. PubMed ID: 16855602 [No Abstract] [Full Text] [Related]
6. A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation. Liu J; Gallo RM; Duffy C; Brutkiewicz RR Viral Immunol; 2016 Sep; 29(7):409-16. PubMed ID: 27327902 [TBL] [Abstract][Full Text] [Related]
7. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704 [TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 US3 Phosphorylates Cellular KIF3A To Downregulate CD1d Expression. Xiong R; Rao P; Kim S; Li M; Wen X; Yuan W J Virol; 2015 Jul; 89(13):6646-55. PubMed ID: 25878107 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791 [TBL] [Abstract][Full Text] [Related]
10. Viral danger signals control CD1d de novo synthesis and NKT cell activation. Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929 [TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521 [TBL] [Abstract][Full Text] [Related]
12. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. Raftery MJ; Winau F; Kaufmann SH; Schaible UE; Schönrich G J Immunol; 2006 Nov; 177(9):6207-14. PubMed ID: 17056550 [TBL] [Abstract][Full Text] [Related]
13. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Lang GA; Maltsev SD; Besra GS; Lang ML Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206 [TBL] [Abstract][Full Text] [Related]
14. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. Posavad CM; Newton JJ; Rosenthal KL J Virol; 1994 Jun; 68(6):4072-4. PubMed ID: 8189546 [TBL] [Abstract][Full Text] [Related]
15. NKT cells are not critical for HSV-1 disease resolution. Cornish AL; Keating R; Kyparissoudis K; Smyth MJ; Carbone FR; Godfrey DI Immunol Cell Biol; 2006 Feb; 84(1):13-9. PubMed ID: 16277640 [TBL] [Abstract][Full Text] [Related]
16. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785 [TBL] [Abstract][Full Text] [Related]